stoxline Quote Chart Rank Option Currency Glossary
  
Guardian Pharmacy Services, Inc. (GRDN)
19.75  -0.49 (-2.42%)    02-14 16:00
Open: 20.29
High: 20.495
Volume: 58,309
  
Pre. Close: 20.24
Low: 19.475
Market Cap: 1,250(M)
Technical analysis
2025-02-14 4:48:31 PM
Short term     
Mid term     
Targets 6-month :  25.24 1-year :  27.28
Resists First :  21.61 Second :  23.36
Pivot price 21.56
Supports First :  18.78 Second :  15.62
MAs MA(5) :  20.11 MA(20) :  21.47
MA(100) :  0 MA(250) :  0
MACD MACD :  -0.4 Signal :  -0.1
%K %D K(14,3) :  22.8 D(3) :  18.8
RSI RSI(14): 39.5
52-week High :  25.73 Low :  15.52
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ GRDN ] has closed above bottom band by 11.4%. Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 20.55 - 20.67 20.67 - 20.76
Low: 19.11 - 19.26 19.26 - 19.39
Close: 19.52 - 19.75 19.75 - 19.94
Company Description

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

Headline News

Tue, 11 Feb 2025
Guardian Pharmacy Executives Receive Equity Awards - Investing.com

Sun, 09 Feb 2025
Calamos Advisors LLC Boosts Stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN) - MarketBeat

Fri, 07 Feb 2025
Guardian Pharmacy Services (GRDN) to Release Earnings on Tuesday - MarketBeat

Wed, 08 Jan 2025
Brown Advisory Inc's Strategic Acquisition of Guardian Pharmacy Services Inc Shares - GuruFocus.com

Tue, 17 Dec 2024
Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy - Business Wire

Thu, 10 Oct 2024
Guardian Pharmacy goes public, raises $112M as investors see gold in aging - The Atlanta Journal Constitution

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Distribution
Shares Out 9 (M)
Shares Float 0 (M)
Held by Insiders 0.3 (%)
Held by Institutions 22.2 (%)
Shares Short 9 (K)
Shares Short P.Month 81 (K)
Stock Financials
EPS -1.38
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 1.2 %
Operating Margin 5.6 %
Return on Assets (ttm) 7.4 %
Return on Equity (ttm) 45.5 %
Qtrly Rev. Growth 18.3 %
Gross Profit (p.s.) 24.25
Sales Per Share 121.73
EBITDA (p.s.) 5.77
Qtrly Earnings Growth 0 %
Operating Cash Flow 67 (M)
Levered Free Cash Flow 42 (M)
Stock Valuations
PE Ratio -14.32
PEG Ratio 0
Price to Book value 0
Price to Sales 0.16
Price to Cash Flow 2.7
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android